- Home
- YMAB vs AIP Comparison
YMAB vs AIP Comparison
Compare YMAB & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- AIP
- Stock Information
- Founded
- YMAB 2015
- AIP 2003
- Country
- YMAB United States
- AIP United States
- Employees
- YMAB N/A
- AIP N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- AIP Semiconductors
- Sector
- YMAB Health Care
- AIP Technology
- Exchange
- YMAB Nasdaq
- AIP Nasdaq
- Market Cap
- YMAB 218.4M
- AIP 244.1M
- IPO Year
- YMAB 2018
- AIP 2021
- Fundamental
- Price
- YMAB $3.89
- AIP $7.25
- Analyst Decision
- YMAB Buy
- AIP Strong Buy
- Analyst Count
- YMAB 11
- AIP 4
- Target Price
- YMAB $18.73
- AIP $12.75
- AVG Volume (30 Days)
- YMAB 216.5K
- AIP 183.4K
- Earning Date
- YMAB 05-13-2025
- AIP 05-13-2025
- Dividend Yield
- YMAB N/A
- AIP N/A
- EPS Growth
- YMAB N/A
- AIP N/A
- EPS
- YMAB N/A
- AIP N/A
- Revenue
- YMAB $87,685,000.00
- AIP $57,724,000.00
- Revenue This Year
- YMAB N/A
- AIP $19.68
- Revenue Next Year
- YMAB $18.83
- AIP $18.13
- P/E Ratio
- YMAB N/A
- AIP N/A
- Revenue Growth
- YMAB 3.38
- AIP 7.56
- 52 Week Low
- YMAB $3.84
- AIP $5.46
- 52 Week High
- YMAB $17.47
- AIP $12.64
- Technical
- Relative Strength Index (RSI)
- YMAB 40.44
- AIP 57.98
- Support Level
- YMAB $3.76
- AIP $6.64
- Resistance Level
- YMAB $4.60
- AIP $7.74
- Average True Range (ATR)
- YMAB 0.33
- AIP 0.36
- MACD
- YMAB -0.02
- AIP 0.17
- Stochastic Oscillator
- YMAB 15.12
- AIP 75.68
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About AIP Arteris Inc.
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.